D. E. Shaw & Co., Inc. - KYMERA THERAPEUTICS INC ownership

KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of KYMERA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$800,958
+138.1%
27,032
+100.5%
0.00%
Q4 2022$336,436
+43.2%
13,479
+24.6%
0.00%
Q3 2022$235,000
-58.7%
10,817
-26.1%
0.00%
-100.0%
Q1 2021$569,000
-71.0%
14,645
-53.6%
0.00%
-50.0%
Q4 2020$1,959,00031,5920.00%
Other shareholders
KYMERA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Deer IX & Co. Ltd. 1,755,356$97,949,00048.97%
Trustees of Columbia University in the City of New York 463,298$28,724,00038.38%
AJU IB Investment Co., Ltd. 704,059$43,652,00016.52%
BVF INC/IL 2,630,658$163,101,0006.42%
Redmile Group, LLC 2,720,489$168,670,0002.04%
Bain Capital Life Sciences Investors, LLC 479,605$29,735,0001.87%
Rock Springs Capital Management LP 713,865$44,260,0000.94%
SPHERA FUNDS MANAGEMENT LTD. 147,700$9,157,0000.81%
HighVista Strategies LLC 17,117$1,061,0000.68%
Logos Global Management LP 110,920$6,877,0000.59%
View complete list of KYMERA THERAPEUTICS INC shareholders